Company: LRHC
Filing Date: 2025-08-20
Form Type: S-1/A
Source: 0001213900-25-078966
Chunk: 27

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-20
Form: S-1/A
Chunk 27
---
 of shares of our common stock to the Selling Stockholder, or the anticipation of such sales, could make it more difficult for us
to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.

Sales of a substantial number of our securities in the public market by the Selling Stockholder and/or by our existing securityholders could cause the price of our shares of common stock to fall.

The Selling Stockholder can sell, under this Prospectus,
up to 100,000,000 shares of common stock. Sales of a substantial number of our shares of common stock in the public market by the
Selling Stockholder and/or by our other existing securityholders, or the perception that those sales might occur, could depress the market
price of our shares of common stock and could impair our ability to raise capital through the sale of additional equity securities. We
are unable to predict the effect that such sales may have on the prevailing market price of our shares of common stock.

Risks Related to the Facility

It is not possible to predict the actual number of shares of common stock we may sell to the Selling Stockholder under the Facility, or the actual gross proceeds resulting from such sales.

Because the purchase price per share to be paid
by the Selling Stockholder for the shares of common stock that we may elect to sell to the Selling Stockholder under the Facility, if any, will fluctuate based on the market
prices of our common stock at the time we elect to sell shares to the Selling Stockholder pursuant to the Facility, if any, it is not possible for us to
predict, as of the date of this Prospectus and prior to any such sales, the number of shares of common stock that we will sell to the Selling Stockholder
under the Facility, the purchase price per share that the Selling Stockholder will pay for shares purchased from us under the Facility, or the aggregate
gross proceeds that we will receive from those purchases by the Selling Stockholder under the Facility.

<div align='center'>14</div>

The Company cannot effect any sales under
the Facility and the Selling Stockholder will not have any obligation to purchase shares of our common stock under the Facility to the
extent that after giving effect to such purchase and sale the aggregate number of shares of common stock issued under the Facility together
with any shares of common stock issued in connection with any other transaction that may be considered part of the same series of transactions,
where the number of shares issued would exceed